Crosthan Tablet (Clonixin Lysinate)

Adult dose

○ Adults: Administer 125∼250 mg of clonixin lysinate orally 3 times daily.

This medication should be consulted with a physician or pharmacist before use by anyone who regularly drinks more than three glasses of alcohol a day. There is a risk of gastrointestinal bleeding if alcohol is frequently consumed while taking this medication. This medication may affect the cardiovascular system and increase the risk of serious thrombotic responses, such as myocardial infarction and stroke. Those with cardiovascular diseases or risk factors should be particularly cautious and closely monitor cardiovascular symptoms with their physician. Additionally, this medication can cause gastrointestinal side effects, leading to bleeding, ulcers, or perforation of the stomach or intestines. Particularly, the elderly or those with a history of gastrointestinal diseases are at greater risk and should exercise caution. Patients with peptic ulcers, those allergic to any component of this medication, and those with hypersensitivity to aspirin or other non-steroidal anti-inflammatory drugs should not take this medication. Pregnant women or those who may become pregnant, and patients with severe liver impairment, kidney impairment, or heart failure should also avoid this medication. Caution should be exercised to avoid taking this medication in combination with other non-steroidal anti-inflammatory drugs, certain antihypertensives, diuretics, lithium, methotrexate, anticoagulants, etc., as the risk of side effects may increase. It is advisable to avoid breastfeeding while taking this medication, and if any abnormal symptoms (nausea, vomiting, abdominal pain, skin rash, anemia, liver function abnormalities, etc.) occur, discontinue use immediately and consult a physician. This medication should be taken at the lowest effective dose for the shortest duration necessary, and blood tests along with liver and kidney function tests should be performed regularly if taken long-term. Individuals with hypertension, heart failure, or kidney or liver diseases should carefully monitor their condition according to their physician's instructions before and during treatment with this medication. This medication can cause severe allergic reactions on the skin, so if a rash or itching occurs, it should be discontinued immediately. Finally, it is safest to keep this medication out of the reach of children and not transfer it to other containers.

Gastrointestinal bleeding, serious cardiovascular thrombotic reactions, myocardial infarction, stroke, bleeding in the stomach or intestines, ulcers, perforation, nausea, vomiting, diarrhea, constipation, abdominal pain, peptic ulcer, perforation, shock, rash, itching, anemia, elevated AST, elevated ALT, drowsiness, headache, dizziness, cold sweat, chill, abnormal euphoria, jaundice, fulminant hepatitis, liver necrosis, liver failure, anemia, exfoliative dermatitis, Stevens-Johnson syndrome, toxic epidermal necrolysis, severe bronchospasm

This medication should be stored in a tightly closed container to avoid exposure to air or moisture. It is best to maintain a storage temperature between 1 and 30 degrees Celsius to safely preserve the medication's effectiveness.

Appearance

Orange rectangular film-coated tablet

Package unit

10 tablets/PTP